MicroRNAs and SGLT2 inhibitors in cardiovascular disease: Shared pathways and emerging roles
{{output}}
MicroRNAs are non-coding RNA sequences capable of transport outside the cell to regulate essential cellular processes. They are able to induce structural changes implicated in prevalent cardiovascular conditions such as heart failure, atherosclerosis and myoca... ...
